C-reactive protein: Structural biology and host defense function

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 3, 1999, Pages 265-270

  Szalai, Alexander J ^a,e   Agrawal, Alok ^a,d   Greenhough, Trevor J ^b   Volanakis, John E ^a,c  

^a University of Alabama at Birmingham   (United States)

^b KEELE UNIVERSITY   (United Kingdom)

^c BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^d METROHEALTH MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Acute phase proteins; Crystal structure; Inflammation

Indexed keywords

ASPARTIC ACID; C REACTIVE PROTEIN; CALCIUM ION; COMPLEMENT COMPONENT C1Q; PHOSPHORYLCHOLINE; TYROSINE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; BACTEREMIA; BACTERIAL INFECTION; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; GENE MUTATION; HOST RESISTANCE; HYDROPHOBICITY; LIFESPAN; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; TRANSGENE;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS MUSCULUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032940592     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.046     Document Type: Conference Paper

References (32)

1. Shrive AK, Cheetham GMT, Holden D, Myles DAA, Turnell WG, Volanakis JE, et al. Three dimensional structure of human C-reactive protein. Nature Struct Biol 1996; 3:346-54.
2. Abernathy TJ, Avery OT. The occurrence during acute infections of a protein not normally present in the blood. I. Distribution of the reactive protein in patient's sera and the effect of calcium on the flocculation reaction with C-polysaccharide of pneumococcus. J Exp Med 1941; 73:173-82.
3. Volanakis JE, Kaplan MH. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med 1971; 136:612-4.
4. Baldo BA, Fletcher TC, Pepys J. Isolation of a peptido-polysaccharide from the dermatophyte Epidermophyton floccosum and a study of its reaction with human C-reactive protein and a mouse antiphosphorylcholine myeloma serum. Immunology 1977; 32:831-42.
5. Löfstrom G. Comparison between the reactions of acute phase serum with pneumococcus C-polysaccharide and with pneumococcus type 27. Br J Exp Pathol 1944; 25: 21-6.
6. Volanakis JE, Wirtz KWA. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature 1979; 281:155.
7. Agrawal A, Kilpatrick JM, Volanakis JE. Structure and function of human C-reactive protein. In: Mackiewicz A, Kushner I, Baumann H, editors. Acute phase proteins: molecular biology, biochemistry, and clinical applications. Ann Arbor MI: CRC Press, 1993:79-92.
8. Volanakis JE, Xu Y, Macon KJ. Human C-reactive protein and host defense. In: Marchalonis JJ, Reinisch CL, editors. Defense molecules. New York: Alan R Liss, 1990:161-75.
9. Srinivasan N, White HE, Emsley J, Wood SP, Pepys MB, Blundell TL. Comparative analyses of pentraxins: implications for protomer assembly and ligand binding. Structure 1994; 2:1017-27.
10. Agrawal A, Xu Y, Ansardi D, Macon KJ, Volanakis JE. Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis. J Biol Chem 1992; 267:25352-8.
11. 67. J Immunol 1997; 158:345-50.
12. Emsley J, White HE, O'Hara BP, Oliva G, Srinivasan N, Tickle IJ, et al. Structure of pentameric human serum amyloid P component. Nature 1994; 367:338-45.
13. Wong GG, Witek JS, Temple PA, Wilkens KM, Leary AC, Luxenberg DP, et al. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 1985; 228:810-15.
14. Kilpatrick JM, Kearney JF, Volanakis JE. Demonstration of calcium-induced conformational change(s) in C-reactive protein by using monoclonal antibodies. Mol Immunol 1982; 19:1159-65.
15. Volanakis JE, Kaplan MH. Interaction of C-reactive protein complexes with the complement system. II. Consumption of Guinea pig complement by CRP complexes. Requirement for human Clq. J Immunol 1974; 113:9-17.
16. Cooper NR. The classical complement pathway. Activation and regulation of the first complement component. Adv Immunol 1985; 37:151-216.
17. Agrawal A, Volanakis JE. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis. J Immunol 1994; 152:5404-10.
18. Agrawal A, Shrive AK, Greenhough TJ, Volanakis JE. Tyrosine 175 of human C-reactive protein is critical for complement activation: structure of the C1q-binding site (submitted).
19. Pepys MB, Baltz ML, Gomer K, Davies AJS, Doenhoff M. Serum amyloid P component is an acute-phase reactant in the mouse. Nature 1979; 278:259-61.
20. Ciliberto G, Arcone R, Wagner EF, Rüther U. Inducible and tissue-specific expression of human C-reactive protein in transgenic mice. EMBO J 1987; 6:4017-22.
21. Murphy C, Beckers J, Rüther U. Regulation of the human C-reactive protein gene in transgenic mice. J Biol Chem 1995; 270:704-8.
22. Klein L, Klein T, Rüther U, Kyewski B. CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med 1998; 188:5-16.
23. Szalai AJ, Briles DE, Volanakis JE. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol 1995; 155: 2557-63.
24. Szalai AJ, van Ginkel FW, Dalrymple SA, Murray R, McGhee JR, Volanakis JE. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J Immunol 1998; 160:5294-9.
25. Volanakis JE. Complement activation by C-reactive protein complexes. Ann NY Acad Sci 1982; 389:235-50.
26. Szalai AJ, Briles DE, Volanakis JE. The role of complement in C-reactive protein mediated protection of mice from Streptococcus pneumoniae. Infect Immun 1996; 64: 4850-53.
27. Horowitz J, Volanakis JE, Briles DE. Blood clearance of Streptococcus pneumoniae by C-reactive protein. J Immunol 1987; 138:2598-603.
28. Ganrot PO, Kindmark CO. C-reactive protein - a phagocytosis promoting factor. Scand J Clin Lab Invest 1969; 24:215-9.
29. Nakayama S, Gewurz H, Holzer T, DuClos TW, Mold C. The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection. Clin Exp Immunol 1983; 54:319-26.
30. Gilkeson GS, Garnier G, Circolo A, Wetsel R, Holers V, Feagin A, et al. Modulation of renal disease in lupus mice deficient in complement component C3. Immunopharmacology 1998; In press.
31. Hosea SW, Brown EJ, Frank MM. The critical role of complement in experimental pneumococcal sepsis. J Infect Dis 1980; 142:903-9.
32. Marnell LL, Mold C, Volzer MA, Burlingame RW, DuClos TW. C-reactive protein binds to FcγR1 in transfected COS cells. J Immunol 1995; 155:2185-93.